Understanding Alzheimer's Risk and Immune Health in Heart Disease

About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
July 01, 2024 - June 30, 2027
Grant ID
A2024024S
Co-Principal Investigator(s)
Whitney Wharton, PhD, Emory University
Goals
This study will examine the relationship between renin-angiotensin-aldosterone system function, cognitive function, and Alzheimer’s disease blood biomarkers with peripheral inflammation and immune cells.
Summary
This study explores how the immune system relates to memory, cognition, and Alzheimer’s risk in middle-aged adults with heart conditions. As heart problems surge in the under-65 population, the connection to cognitive decline and Alzheimer’s remains unclear. Surveys, blood tests, and memory assessments will be used to better understand how factors like high blood pressure affect cognition and may elevate Alzheimer’s risk. Insights into heart health, immunity, and Alzheimer’s can benefit at-risk individuals and shape future treatments.
Unique and Innovative
This proposal innovates by (1) targeting an unstudied group at risk for AD, potentially identifying a new intervention target. (2) It uses peripheral blood biomarkers, making research more accessible and representative, bypassing common exclusion criteria. (3) By including immune cell biomarkers, it offers a minimally invasive method, particularly beneficial for diverse groups with AD risk factors.
Foreseeable Benefits
By establishing a target group and solidifying measures for intervention, this study will lead to identification of an important but previously overlooked risk group for which both lifestyle and pharmaceutical interventions could be developed. This study includes comprehensive measures of social determinants of health to examine potential sociocultural, structural, and biological factors related to higher AD risk. Examining these biomarkers in a racially diverse group with known vascular risk factors for AD may shed further light on these mechanisms.
Grants
Related Grants
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Dysregulated Astrocyte p38, Brain Inflammation, and Alzheimer's Pathology
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Linda Van Eldik, PhD
Dysregulated Astrocyte p38, Brain Inflammation, and Alzheimer's Pathology
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Linda Van Eldik, PhD
Alzheimer's Disease Research
Regulation of Microglia Phenotypes in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Johannes Schlachetzki, MD
Regulation of Microglia Phenotypes in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Johannes Schlachetzki, MD